当前位置:首页 - 行情中心 - 药明康德(603259) - 财务分析

药明康德

(603259)

  

流通市值:1534.56亿  总市值:1772.07亿
流通股本:25.01亿   总股本:28.88亿

药明康德(603259)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润37.15亿元,每股收益1.29元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益6277876.18万元,未分配利润3567960.15万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产8451208.81万元,负债2173332.63万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入9,654,595,304.2839,241,431,359.8827,702,002,254.7617,240,918,263.02
营业总成本6,712,128,987.7227,342,268,206.8819,967,164,047.6212,203,655,162.93
营业利润4,292,748,775.2911,580,174,718.147,890,869,263.365,078,454,076.27
利润总额4,279,893,550.8811,539,811,639.087,854,296,089.215,049,553,770.35
净利润3,715,468,841.049,567,739,539.186,601,611,515.974,280,845,682.91
其他综合收益118,473,436.43185,718,884.52-3,353,834.7614,733,694.61
综合收益总额3,833,942,277.479,753,458,423.76,598,257,681.214,295,579,377.52
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计43,308,063,148.9438,690,152,263.9930,462,748,877.1230,261,138,249.11
非流动资产合计41,204,024,944.2941,635,672,144.7643,775,490,998.1144,136,190,407.78
资产总计84,512,088,093.2380,325,824,408.7574,238,239,875.2374,397,328,656.89
流动负债合计18,873,805,072.3216,226,114,890.712,927,421,099.0213,648,375,448.31
非流动负债合计2,859,521,263.65,014,095,882.485,727,576,674.225,654,192,029.3
负债合计21,733,326,335.9221,240,210,773.1818,654,997,773.2419,302,567,477.61
归属于母公司股东权益合计62,332,382,757.1158,632,715,174.3755,173,547,660.3854,713,936,892.47
股东权益合计62,778,761,757.3159,085,613,635.5755,583,242,101.9955,094,761,179.28
负债和股东权益合计84,512,088,093.2380,325,824,408.7574,238,239,875.2374,397,328,656.89
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计11,640,339,447.6943,465,208,735.1431,246,847,172.8320,572,914,715.29
经营活动现金流出小计8,444,909,585.9731,058,693,900.5522,867,754,787.6815,606,620,527.92
经营活动产生的现金流量净额3,195,429,861.7212,406,514,834.598,379,092,385.154,966,294,187.37
投资活动现金流入小计4,078,846,761.7111,987,982,568.265,519,181,400.723,331,857,536.15
投资活动现金流出小计1,879,090,566.0417,506,159,695.018,713,398,273.855,306,598,872.73
投资活动产生的现金流量净额2,199,756,195.67-5,518,177,126.75-3,194,216,873.13-1,974,741,336.58
筹资活动现金流入小计4,767,126,048.911,986,352,535.198,282,155,280.665,575,838,145.11
筹资活动现金流出小计3,531,089,417.3515,818,543,183.2214,187,039,758.569,037,526,297.46
筹资活动产生的现金流量净额1,236,036,631.55-3,832,190,648.03-5,904,884,477.9-3,461,688,152.35
汇率变动对现金及现金等价物的影响-61,078,422.61387,525,345.81-9,427,113.53168,611,655.79
现金及现金等价物净增加额6,570,144,266.333,443,672,405.62-729,436,079.41-301,523,645.77
期末现金及现金等价物余额20,014,855,483.9713,444,711,217.649,271,602,732.619,699,515,166.25
最新报告期:2025-05-09
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
招商证券梁广楷,许菲菲4.214.505.332025-05-09
国信证券彭思宇3.864.415.022025-05-09
中信建投汤然,刘若飞,贺菊颖,赖俊勇4.174.395.022025-05-03
中金公司张琎,吴婉桦3.974.57--2025-05-01
招银国际JillWu,BenchenHuang------2025-04-30
TOP↑